MAURY HARDEN: Open Payments
NPI 1366157976 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 13 payments from 7 companies in 2025. Trend: 2023 $375 · 2024 $257 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $56 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $46 |
| MILLICENT US INC | 2 | $44 |
| Baxter Healthcare | 1 | $28 |
| Evofem Biosciences, Inc. | 3 | $27 |
| Organon LLC | 1 | $21 |
| Hologic Sales and Service, LLC | 1 | $20 |
Products named: Veozah, PERCLOT, Phexxi, FEMLYV, NEXPLANON, INTRAROSA, APTIMA.
Industry payments across AL — which companies pay providers there.
